SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,178.00    -4.00 (-0.18%)
Bid:
2,192.00
Ask:
2,220.00
Spread: 28.00 (1.277%)
Market Cap: £1.45b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

15 Sep 2023 13:07

RNS Number : 6487M
Genus PLC
15 September 2023
 

15 September 2023

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting on 14 September 2023 of conditional nil-cost options granted in 2020 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in table A below; and conditional nil-cost options granted in 2020 under the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table B below, members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2023 on the London Stock Exchange, to offset income tax and social security liabilities due on the exercises and retained the balance of ordinary shares.

 

Conditional nil-cost options granted under the PSP were subject to relevant performance conditions, measured over a three-year performance period which commenced on 1 July 2020 and ended on 30 June 2023. Following assessment of the performance conditions, the Remuneration Committee determined that the awards would vest at 36% of the original grant and the balance of the awards have lapsed.

 

Genus also announces that, further to the vesting on 14 September 2023 of conditional share awards granted in 2020 and 2022 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in table C below, Matt Culbertson, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2023 on the London Stock Exchange, to offset income tax and social security liabilities due on the releases and retained the balance of ordinary shares.

 

Conditional share awards were granted to Matt Culbertson under the PSP prior to him becoming a member of GELT. These conditional share awards were not subject to company performance conditions.

 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 14 September 2023.

 

For further information please contact:

 

Genus:

Cara Guedeney, Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

 

Table A - GELT 2019 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Matt Culbertson

3. Nate Zwald

4. Jerry Thompson

5. Dan Hartley

6. Angelle Rosata

2.

Reason for the notification

a.

Position/status

1. Executive Director

2. Chief Operating Officer Genus PIC

3. Chief Operating Officer Genus ABS Dairy

4. Chief Operating Officer Genus ABS Beef

5. Group General Counsel & Company Secretary

6. Group Human Resources Director

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of nil-cost options under the PSP.

c.

Price(s) and volume(s)

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 0p

11,116

2. 0p

1,880

3. 0p

3,908

4. 0p

3,829

5. 0p

3,872

6. 0p

3,663

d.

Aggregated information

· Aggregated volume

· Price

 

Price(s)

Volume(s)

1. 0p

11,116

2. 0p

1,880

3. 0p

3,908

4. 0p

3,829

5. 0p

3,872

6. 0p

3,663

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

 

 

e.

Date of the transaction

2023-09-14

f.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 2,142.2049p

5,241

2. 2,148.7598p

666

3. 2,146.7835p

1,968

4. 2,159.2511p

2,019

5. 2,143.1358p

1,826

6. 2,140.0000p

1,711

d.

Aggregated information

· Aggregated volume

· Price

 

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 2,142.2049p

5,241

2. 2,148.7598p

666

3. 2,146.7835p

1,968

4. 2,159.2511p

2,019

5. 2,143.1358p

1,826

6. 2,140.0000p

1,711

e.

Date of the transaction

2023-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

Table B - GELT Deferred Share Bonus Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Matt Culbertson

3. Nate Zwald

4. Jerry Thompson

5. Dan Hartley

6. Angelle Rosata

2.

Reason for the notification

a.

Position/status

1. Executive Director

2. Chief Operating Officer Genus PIC

3. Chief Operating Officer Genus ABS Dairy

4. Chief Operating Officer Genus ABS Beef

5. Group General Counsel & Company Secretary

6. Group Human Resources Director

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of nil-cost options under the DSBP.

c.

Price(s) and volume(s)

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 0p

8,079

2. 0p

1,810

3. 0p

1,518

4. 0p

1,511

5. 0p

1,651

6. 0p

1,538

d.

Aggregated information

· Aggregated volume

· Price

 

Price(s)

Volume(s)

1. 0p

8,079

2. 0p

1,810

3. 0p

1,518

4. 0p

1,511

5. 0p

1,651

6. 0p

1,538

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

 

 

 

 

 

 

 

 

e.

Date of the transaction

2023-09-14

f.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 2,138.1111p

3,809

2. 2,157.7285p

641

3. 2,159.1111p

765

4. 2,154.0176p

797

5. 2,160.6444p

779

6. 2,140.0000p

719

d.

Aggregated information

· Aggregated volume

· Price

 

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1. 2,138.1111p

3,809

2. 2,157.7285p

641

3. 2,159.1111p

765

4. 2,154.0176p

797

5. 2,160.6444p

779

6. 2,140.0000p

719

e.

Date of the transaction

2023-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

Table C - GELT 2019 Performance Share Plan Release

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Matt Culbertson

2.

Reason for the notification

b.

Position/status

Chief Operating Officer Genus PIC

c.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

d.

Name

Genus plc

e.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

f.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

g.

Nature of the transaction

Release of conditional share awards under the PSP.

h.

Price(s) and volume(s)

 

Price(s)

Volume(s)

0p

2,238

0p

584

i.

Aggregated information

· Aggregated volume

· Price

 

Price(s)

Volume(s)

0p

2,238

0p

584

j.

Date of the transaction

2023-09-14

k.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the release of conditional share awards under the PSP to offset income tax and social security liabilities due on the release.

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

2,120.3822p

793

2,120.3822p

208

d.

Aggregated information

· Aggregated volume

· Price

 

 

Price(s)

Volume(s)

2,120.3822p

793

2,120.3822p

208

e.

Date of the transaction

2023-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUVRURONUKAAR
Date   Source Headline
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.